282 related articles for article (PubMed ID: 27643807)
1. Muscle spindle alterations precede onset of sensorimotor deficits in Charcot-Marie-Tooth type 2E.
Villalón E; Jones MR; Sibigtroth C; Zino SJ; Dale JM; Landayan DS; Shen H; Cornelison DD; Garcia ML
Genes Brain Behav; 2017 Feb; 16(2):260-270. PubMed ID: 27643807
[TBL] [Abstract][Full Text] [Related]
2. Muscle pathology without severe nerve pathology in a new mouse model of Charcot-Marie-Tooth disease type 2E.
Shen H; Barry DM; Dale JM; Garcia VB; Calcutt NA; Garcia ML
Hum Mol Genet; 2011 Jul; 20(13):2535-48. PubMed ID: 21493625
[TBL] [Abstract][Full Text] [Related]
3. Exacerbation of Charcot-Marie-Tooth type 2E neuropathy following traumatic nerve injury.
Villalón E; Dale JM; Jones M; Shen H; Garcia ML
Brain Res; 2015 Nov; 1627():143-53. PubMed ID: 26423936
[TBL] [Abstract][Full Text] [Related]
4. Expressing hNF-LE397K results in abnormal gaiting in a transgenic model of CMT2E.
Dale JM; Villalon E; Shannon SG; Barry DM; Markey RM; Garcia VB; Garcia ML
Genes Brain Behav; 2012 Apr; 11(3):360-5. PubMed ID: 22288874
[TBL] [Abstract][Full Text] [Related]
5. Reversal of neuropathy phenotypes in conditional mouse model of Charcot-Marie-Tooth disease type 2E.
Dequen F; Filali M; Larivière RC; Perrot R; Hisanaga S; Julien JP
Hum Mol Genet; 2010 Jul; 19(13):2616-29. PubMed ID: 20421365
[TBL] [Abstract][Full Text] [Related]
6. Myelinated axons fail to develop properly in a genetically authentic mouse model of Charcot-Marie-Tooth disease type 2E.
Lancaster E; Li J; Hanania T; Liem R; Scheideler MA; Scherer SS
Exp Neurol; 2018 Oct; 308():13-25. PubMed ID: 29940160
[TBL] [Abstract][Full Text] [Related]
7. Clinical and morphological variability of the E396K mutation in the neurofilament light chain gene in patients with Charcot-Marie- Tooth disease type 2E.
Elbracht M; Senderek J; Schara U; Nolte K; Klopstock T; Roos A; Reimann J; Zerres K; Weis J; Rudnik-Schöneborn S
Clin Neuropathol; 2014; 33(5):335-43. PubMed ID: 24887401
[TBL] [Abstract][Full Text] [Related]
8. NEFL N98S mutation: another cause of dominant intermediate Charcot-Marie-Tooth disease with heterogeneous early-onset phenotype.
Berciano J; Peeters K; García A; López-Alburquerque T; Gallardo E; Hernández-Fabián A; Pelayo-Negro AL; De Vriendt E; Infante J; Jordanova A
J Neurol; 2016 Feb; 263(2):361-369. PubMed ID: 26645395
[TBL] [Abstract][Full Text] [Related]
9. NEFL E396K mutation is associated with a novel dominant intermediate Charcot-Marie-Tooth disease phenotype.
Berciano J; García A; Peeters K; Gallardo E; De Vriendt E; Pelayo-Negro AL; Infante J; Jordanova A
J Neurol; 2015 May; 262(5):1289-300. PubMed ID: 25877835
[TBL] [Abstract][Full Text] [Related]
10. Neurofilament light polypeptide gene N98S mutation in mice leads to neurofilament network abnormalities and a Charcot-Marie-Tooth Type 2E phenotype.
Adebola AA; Di Castri T; He CZ; Salvatierra LA; Zhao J; Brown K; Lin CS; Worman HJ; Liem RK
Hum Mol Genet; 2015 Apr; 24(8):2163-74. PubMed ID: 25552649
[TBL] [Abstract][Full Text] [Related]
11. Painful Charcot-Marie-Tooth neuropathy type 2E/1F due to a novel NEFL mutation.
Doppler K; Kunstmann E; Krüger S; Sommer C
Muscle Nerve; 2017 May; 55(5):752-755. PubMed ID: 27649278
[TBL] [Abstract][Full Text] [Related]
12. Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice.
Klein D; Patzkó Á; Schreiber D; van Hauwermeiren A; Baier M; Groh J; West BL; Martini R
Brain; 2015 Nov; 138(Pt 11):3193-205. PubMed ID: 26297559
[TBL] [Abstract][Full Text] [Related]
13. Genetic and clinical characteristics of
Horga A; Laurà M; Jaunmuktane Z; Jerath NU; Gonzalez MA; Polke JM; Poh R; Blake JC; Liu YT; Wiethoff S; Bettencourt C; Lunn MP; Manji H; Hanna MG; Houlden H; Brandner S; Züchner S; Shy M; Reilly MM
J Neurol Neurosurg Psychiatry; 2017 Jul; 88(7):575-585. PubMed ID: 28501821
[TBL] [Abstract][Full Text] [Related]
14. Charcot-Marie-Tooth disease type 2E, a disorder of the cytoskeleton.
Fabrizi GM; Cavallaro T; Angiari C; Cabrini I; Taioli F; Malerba G; Bertolasi L; Rizzuto N
Brain; 2007 Feb; 130(Pt 2):394-403. PubMed ID: 17052987
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease.
Jordanova A; De Jonghe P; Boerkoel CF; Takashima H; De Vriendt E; Ceuterick C; Martin JJ; Butler IJ; Mancias P; Papasozomenos SCh; Terespolsky D; Potocki L; Brown CW; Shy M; Rita DA; Tournev I; Kremensky I; Lupski JR; Timmerman V
Brain; 2003 Mar; 126(Pt 3):590-7. PubMed ID: 12566280
[TBL] [Abstract][Full Text] [Related]
16. Intermediate forms of Charcot-Marie-Tooth neuropathy: a review.
Nicholson G; Myers S
Neuromolecular Med; 2006; 8(1-2):123-30. PubMed ID: 16775371
[TBL] [Abstract][Full Text] [Related]
17. Sensorimotor and cognitive function of a NEFL(P22S) mutant model of Charcot-Marie-Tooth disease type 2E.
Filali M; Dequen F; Lalonde R; Julien JP
Behav Brain Res; 2011 Jun; 219(2):175-80. PubMed ID: 21168446
[TBL] [Abstract][Full Text] [Related]
18. Giant axon and neurofilament accumulation in Charcot-Marie-Tooth disease type 2E.
Fabrizi GM; Cavallaro T; Angiari C; Bertolasi L; Cabrini I; Ferrarini M; Rizzuto N
Neurology; 2004 Apr; 62(8):1429-31. PubMed ID: 15111691
[TBL] [Abstract][Full Text] [Related]
19. Disruption of neurofilament network with aggregation of light neurofilament protein: a common pathway leading to motor neuron degeneration due to Charcot-Marie-Tooth disease-linked mutations in NFL and HSPB1.
Zhai J; Lin H; Julien JP; Schlaepfer WW
Hum Mol Genet; 2007 Dec; 16(24):3103-16. PubMed ID: 17881652
[TBL] [Abstract][Full Text] [Related]
20. Phenotype of Charcot-Marie-Tooth disease Type 2.
Bienfait HM; Baas F; Koelman JH; de Haan RJ; van Engelen BG; Gabreëls-Festen AA; Ongerboer de Visser BW; Meggouh F; Weterman MA; De Jonghe P; Timmerman V; de Visser M
Neurology; 2007 May; 68(20):1658-67. PubMed ID: 17502546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
